Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
USRetina is the largest independent association of retina practices in the United States, providing specialized technology and business solutions to over 1,200 retina specialists. The company's core offering is RetinaOS, a cloud-based operating system that integrates inventory management, drug purchasing, and clinical analytics specifically for the retina specialty. Through its Group Purchasing Organization (GPO), USRetina enables member practices to access competitive pricing on high-cost biologics and pharmaceuticals. Founded in 2012 and headquartered in Denver, the company was acquired by McKesson in 2024 to strengthen its specialty practice solutions. USRetina helps practices optimize their operational efficiency and financial performance while maintaining a focus on high-quality patient care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on US Retina.